Status:
COMPLETED
The Incidence of Postoperative Re-stratification for Recurrence in Well-differentiated Thyroid Cancer - A Single Tertiary Israeli Center Experience
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Well Differentiated Thyroid Carcinoma
Papillary Thyroid Cancer
Eligibility:
All Genders
38-61 years
Brief Summary
Background After diagnosing well-differentiated thyroid cancer (WDTC), careful assessment of the risk for disease-specific recurrence is essential for deciding between partial (low risk) and completio...
Eligibility Criteria
Inclusion
- All patients who underwent thyroid surgery (partial and total) between 2006-2018 at Tel Aviv Sourasky Medical Center (TASMC) were included
Exclusion
- Patients with evidence of cervical lymph node metastasis, other malignancies, adverse imaging features (i.e., extracapsular spread of thyroid malignancy, vocal cord paralysis or immobility in physical examination) were excluded from the study.
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
301 Patients enrolled
Trial Details
Trial ID
NCT04500925
Start Date
January 1 2006
End Date
January 1 2020
Last Update
August 5 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.